CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Proteinuria

Renal & ElectrolyteLab test / biomarkerriskmodifiable
16
evidence score
PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 6meta-analyses: 0trials: 10genetic: 0MR bonus:

References (3)

0 meta-analyses / systematic reviews

Clinical trials (9)

NCTTitleStatusTypeInterventions
NCT07204743Efficacy and Safety of Dapagliflozin in Children With ProteinuriaACTIVE NOT RECRUITINGINTERVENTIONALDapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy
NCT05283057Effect of Sodium Glucose Transporter 2 Inhibitor Empagliflozin on Proteinuria and Kidney Disease Progression in Patients With Non-diabetic Glomerulonephritis- A Randomized Controlled TrialCOMPLETEDINTERVENTIONALEmpagliflozin 25 MG, placebo
NCT03190694A Study to Assess the Renoprotective Effects of the SGLT2 Inhibitor Dapagliflozin in Non-Diabetic Patients With Proteinuria: a Randomized Double Blind 6-Weeks Cross-Over TrialCOMPLETEDINTERVENTIONALDapagliflozin 10mg
NCT02442921The Effect of Colchicine Treatment on the Progression of Proteinuria in Patients With Diabetic Nephropathy.UNKNOWNINTERVENTIONALColchicine, Placebo
NCT01588795Renal Denervation in Patients With Diabetic Nephropathy and Persistent ProteinuriaCOMPLETEDINTERVENTIONALPercutaneous renal denervation and TMNS, Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
NCT01093157A Dose-finding Pilot Study of ACTH (Adrenocorticotropic Hormone) on the Proteinuria and Serum Lipoprotein Profile in Patients With Idiopathic Membranous Nephropathy (MN)COMPLETEDINTERVENTIONALAdrenocorticotrophic hormone ACTH
NCT00805753A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)COMPLETEDINTERVENTIONALACTH
NCT00199927A Prospective, Randomized, Multicenter Trial Testing the Antiproteinuric Effect of Statins Added to Combined ACE-inhibitor and Angiotensin Receptor Antagonist Therapy in Proteinuric, Chronic NephropathiesCOMPLETEDINTERVENTIONALFluvastatin, standard therapy
NCT02226055An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri LankaCOMPLETEDOBSERVATIONALArterial Stiffness Assessment

Genetic associations (0)

None linked.